Planet Labs Reports 58% Revenue Growth Amid Insider Selling

Planet Labs PBC reported second-quarter 2027 revenue of $116.1 million, marking a 58.14% increase year-over-year. The company also posted record adjusted EBITDA and disclosed an $800 million backlog, signaling strong near-term demand for its satellite data services. According to GN markets/earnings (en-US), these financial metrics drove much of the recent market discussion, with participants highlighting the scale of the revenue jump and the durability of the order book.

Despite the operational strength, the equity has faced headwinds from internal trading activity. Over the past six months, Planet Labs insiders executed 12 open-market sales and zero purchases. Key executives, including CEO William Spencer Marshall and CFO Ashley F. Johnson, sold a combined 710,028 shares for an estimated $21.6 million. This consistent selling by leadership contrasts with the company’s reported growth trajectory and has influenced investor sentiment regarding the stock’s valuation.

Institutional Positions Diverge Sharply

Institutional investors remain split on the company’s outlook. In the most recent quarter, 266 institutional investors increased their holdings while 244 decreased theirs. American Century Companies Inc added 8.58 million shares, a 147.7% increase, representing an estimated $284.5 million in new exposure. Conversely, Canada Pension Plan Investment Board removed 7.22 million shares, cutting its position by 92.1%, and BlackRock Inc reduced its stake by 27.4%, removing approximately $231.4 million in value. These opposing moves suggest a lack of consensus among large holders regarding the risk-reward profile of Planet Labs.

Analysts Trim Targets Amid Guidance

Wall Street analysts have maintained buy ratings on Planet Labs but have adjusted price targets downward in response to softer forward guidance. The median price target from eight analysts stands at $37.50. Recent updates include Dan Ives of Wedbush setting a $50.00 target and Ryan Koontz of Needham at $53.00. In contrast, Anthony Valentini of Goldman Sachs issued a more conservative $20.00 target. The divergence in these figures reflects differing views on how the company will convert its current backlog into future earnings, with some emphasizing pipeline momentum and others focusing on the pace of execution.

Technical Signals Indicate Rebound Potential

Market technicians point to recent capitulation volume and bullish divergences as potential precursors to a price recovery. Observers note that if the stock reclaims key moving averages, it could confirm a broader rebound. However, the path remains uncertain due to the recent drawdowns and the mixed signals from both insider activity and institutional rebalancing. The company’s ability to sustain its 58% revenue growth rate will be the primary determinant of whether the stock stabilizes or continues to fluctuate around current levels.